I still remember back in October/November last year when I talked about getting into CNL and the impressive discoveries they started reporting on. My first buys were around US$4/share if I remember correctly. The stock was hated, and even after the Ramp Zone assays had started rolling in the market provided many opportunities to buy shares below US$6/share. I took off about half of my overweight position once the share price crossed US$10 mark. Today, the share price in NYSE has been making new all time highs above US$12/share. This has been one of my most successful trades of the year.

The lesson is that when the market doesn't seem to care about or react to amazing results, you can get many fantastic opportunities to express with your money that you do care.